Loading...

Table of Content

    28 February 2022, Volume 27 Issue 2
    Liver Failure
    Risk factors of infection in patients with HBV-related ACLF and its influence on prognosis
    HUANG Chong, ZHONG Qi-sheng, YU Kang-kang, LIU Chuan-miao
    2022, 27(2):  148-151. 
    Asbtract ( 257 )   PDF (724KB) ( 199 )  
    References | Related Articles | Metrics
    Objective To investigate the risk factors of infection in hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and its prognosis. Methods Clinical data of patients with HBV-ACLF admitted from 2007 to 2016 were retrospectively analyzed. Risk factors and incidence rates of different kinds of infection were analyzed, as well as the influence of infection on 60-day survival. Results A total of 293 patients with HBV-ACLF in accordance with the Asian Pacific association for the study of the liver (APASL) criteria (except total bilirubin) were included, of which 92 patients complied with ACLF grade 2-3 of European association for the study of the liver (EASL) CLIF-C criteria. Compared with ACLF 0-1 (34%) patients, the incidence rate of overall infection within 60 days was higher in CLIF-C ACLF 2-3 (54%) patients (P=0.001). A total of 162 patients were treated with corticosteroid and the incidence rates of ‘pulmonary infection', ‘invasive fungal infection/other opportunistic infection', and ‘overall infection' were higher than the patients who were not treated with corticosteroid (19% vs 7% P=0.003, 7% vs 0% P=0.001 and 54% vs 24% P<0.001). Cox multivariate analysis revealed that corticosteroid therapy was an independent risk factor of the infection mentioned above. Sixty-day survival rate of ACLF 0-1 patients combined with infection was lower than that of patients without infection (58% vs 77%, P=0.005), but with no significant difference of 60-day survival rate between ACLF 2-3 patients with infection and those without infection. In univariate analysis, age ≥ 45, ACLF grade 2-3 at baseline, pulmonary infection and overall infection were risk factors of death within 60 days. In multivariate analysis, only age ≥ 45 (HR 1.585, 95%CI 1.183-2.591) and ACLF grade 2-3 at baseline (HR 2.542, 95%CI 1.427-3.673) were independent risk factors of death within 60 days. Conclusion There is a high incidence rate of infection in patients with HBV-ACLF, and corticosteroid therapy was the major risk factor. The survival rates of patients belonging to ACLF grade 0-1 decline when infection occurs.
    Predictive value of different scoring models for short-term prognosis of patients with aute-on-chronic liver failure
    WU Huan, WU Long, ZHU Juan-juan, ZHANG Quan, SHEN Xiao-xu
    2022, 27(2):  152-159. 
    Asbtract ( 287 )   PDF (730KB) ( 220 )  
    References | Related Articles | Metrics
    Objective To investigate the independent risk factors of prognosis in patients with acute-on-chronic liver failure (ACLF), and compare the predictive value of different assessment models for short-term prognosis. Methods A total of 246 patients with ACLF admitted to our hospital from July 2018 to September 2020 were enrolled, and divided into survival group and death group according to the treatment end-point and the clinical outcome 3 months after discharge. SPSS and Yibei statistical software were used to compare the clinical data of the patients in the two groups. Receiver operator characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the predictive efficiency of each scoring model on the short-term prognosis. Results There were significant differences of age, white blood cell (WBC), neutrophils (NEU), neutrophils/nymphocytes (NLR), hemoglobin (Hgb), platelets (PLT), alpha-fetoprotein (AFP), total bilirubin (TBil), direct bilirubin (DBil), indirect bilirubin (IBil), creatinine (CR), natrium (Na), prothrombin time (PT), international normalized ratio (INR), prothrombin activity (PTA), lactic acid (LA) and ammonia (AMM) between the 2 groups. The incidence rates of ACLF-related complications, including lung infection and hepatic encephalopathy (HE), hepatorenal syndrome (HS), upper gastrointestinal bleeding, ascites, spontaneous bacterial peritonitis (SBP), in death group were significantly higher than those in survival group. Multivariate logistic regression analysis showed that age, NLR, IBIL, HE, and ascites were independent risk factors affecting short-term prognosis in patients with ACL. The mortality rates of early, middle and end stages of liver failure were 11.54%, 32.89%, and 77.12%, respectively, which were significantly different between the two groups (P<0.001). The average value of different scoring models in the different stages from high to low were end stage of liver failure, middle stage of liver failure, and early stage of liver failure. Except for the Logstic Regression Model (LRM), the differences among the different liver failure stage groups compared by the other 9 scoring models were statistically significant. The values of Child-Turcotte-Pugh score (CTP), end-stage liver disease score (MELD), MELD-Na score (MELD-Na), MESO score (MESO), integrated MELD score (iMELD), Maddrey discriminant function (MDF), Asia Pacific Association for the Study of Liver Diseases ACLF Research Alliance-ACLF (AARC), Age-Bilirubin-INR-Creatinine (ABIC) and Albumin-bilirubin score (ALBI) in survival group were statistically different from those in death group. Divide the different scoring models into 2-3 intervals according to the scores. Fisher exact test was used when the sample size was less than 5. Pearson chi-square test was used when the sample size in the group was greater than 5. The results showed that all the scoring models had significant differences in the comparison of different score intervals between groups (P<0.001). The AUC values of the 10 scoring models were between 0.5 and 0.8, suggesting a certain predictive value for the prognosis of patients with ACLF. Among them, the AUC value of the ARRC scoring model was the largest (AUC=0.765), followed by CTP, ABIC, iMELD, MDF and the AUC values of the above scoring model were all > 0.7. The AUC value of the LRM scoring model was the smallest (AUC=0.586), indicating it had the worst predictive value. Conclusion In addition to the LRM scoring model, the remaining scoring models CTP, ARRC, MELD, MELD-Na, iMELD, MESO, ABIC, MDF, ALBI can better predict the short-term prognosis of ACLF patients, and the ARRC scoring model has the highest predictive value.
    Liver Fibrosis & Cirrhosis
    Research on the prediction model for progressive fibrosis in patients with NAFLD based on Nomogram
    YANG Yong-qin, WANG Xiao-jun, FENG Gong, LI Rong, LIU Xiao-yu, SUN Xue-mei, HE Na
    2022, 27(2):  160-163. 
    Asbtract ( 214 )   PDF (736KB) ( 225 )  
    References | Related Articles | Metrics
    Objective The degree of fibrosis is considered as a determining factor of long-term prognosis for nonalcoholic fatty liver disease (NAFLD). We aimed to develop a novel non-invasive model based on Nomogram to accurately predict progressive fibrosis in patients with NAFLD. Methods A total of 380 NAFLD patients diagnosed by FibroScan were enrolled. Detailed anthropological data and fibrosis related laboratory parameters were collected. Variables independently associated with advanced fibrosis would be used to construct Nomogram prediction models. Ultimately, the diagnostic efficacy of the prediction model were evaluated by receiver operating characteristic (ROC) curve. Results Variables included in the prediction model were as followed: type 2 diabetes mellitus (OR=1.135, 95%CI 1.019-1.265), aspartate aminotransferase (OR=1.005, 95%CI 1.002-1.018), type III procollagen peptide (OR=1.116, 95%CI 1.028-1.212), and type IV collagen (OR=1.097, 95%CI 1.032-1.166). The area under the ROC curve of the Nomogram prediction model was 0.851, with the 95% CI as 0.778-0.925, the sensitivity as 0.900, and the specificity as 0.826, respectively. Conclusion The novel Nomogram model is more accurate in predicting advanced fibrosis and performs significantly better than the APRI, NFS, FIB-4 and BRAD scores reported in the literature. It might be a noninvasive screening tool for advanced fibrosis in overall NAFLD population.
    The predictive value of PC/SD ratio in evaluating the high-risk gastroesophageal varices in patients with hepatitis B virus-related cirrhosis
    CHEN Ying, FANG Qing-qing, CHEN Wei, ZHANG Jun-pei, SHEN Dan-jie, YU Li, JIAN You-rong, LI Feng, WANG Jian, CHEN Shi-yao
    2022, 27(2):  164-168. 
    Asbtract ( 211 )   PDF (687KB) ( 244 )  
    References | Related Articles | Metrics
    Objective To investigate the value of platelet count to spleen diameter (PC/SD) ratio in predicting the high-risk gastroesophageal varices (GEV) in patients with hepatitis B virus (HBV)-related cirrhosis. Methods The patients with HBV-related cirrhosis from January 2018 to December 2020 were divided into a high-risk group and a low-risk group, according to the severity of liver disease and endoscopic performance. The influencing factors of high-risk GEV were analyzed by univariate analysis. Then logistic regression analysis was used to screen out the non-invasive indicators, and diagnostic efficiency were evaluated by receiver operator characteristic (ROC) curve. Results A total of 68 patients were enrolled. Univariate analysis showed that the differences of PC/SD ratio (t=4.141,P<0.01), hemoglobin (t=2.829,P<0.01), platelet count (t=3.324,P<0.01), ascites (χ2 = 6.530,P<0.05), Child-Pugh classification (χ2 = 6.348,P<0.05) and cirrhosis stages (χ2 = 24.882,P<0.01) between the high-risk group and low-risk group were statistically significant. Multivariate analysis showed that PC/SD ratio and cirrhosis stages were independent risk factors for high-risk GEV in patients with HBV-related cirrhosis (OR=0.998, 95%CI: 0.996-1.000, P<0.05;OR=14.088, 95%CI: 3.220-61.629, P<0.01). ROC curve analysis showed that the area under the curve (AUC) of PC/SD ratio in predicting high-risk GEV was 0.781 (95%CI: 0.551-0.811), with an optimal threshold of 596. However, the AUC of PC/SD ratio in predicting the absence of high-risk GEV was 0.888 (95%CI: 0.802, 0.973), with an optimal threshold of 632.7. Conclusion PC/SD ratio could be a preliminary screening indicator for GEV in patients with HBV-related cirrhosis. If PC/SD ratio is less than 596, endoscopy is recommended due to the high possibility of high-risk GEV. If the PC/SD ratio is over 632.7, endoscopy screening could be avoided due to the low possibility of high risk GEV.
    Efficacy and safety of anticoagulation therapy for PVT after splenectomy in patients with liver cirrhosis
    ZHEN Yong, WANG Bing-ji, DU Hua-jin, GAO Xue-jian, WANG Zi-ping, XUAN Ji, ZHANG Zun-shu, WANG Chuan-tai, GENG Jia-bao
    2022, 27(2):  169-173. 
    Asbtract ( 272 )   PDF (683KB) ( 309 )  
    References | Related Articles | Metrics
    Objective To investigate the efficacy and safety of anticoagulation therapy for portal vein thrombosis (PVT) after splenectomy in cirrhosis patients. Methods A total of 106 cirrhosis patients admitted to our hospital from December 2015 to June 2019 who underwent splenectomy were enrolled. They were randomly divided into control group (50 cases) and experimental group (56 cases). Patients in experimental group were treated with low molecular heparin (subcutaneous injection, once a day for a week) combined with warfarin (oral administration, 24 weeks) 24 hours after splenectomy, while the control group received no anticoagulation therapy after splenectomy. The rate of PVT, liver function index, Child-Pugh score, diameter of portal vein (Dpv), velocity of portal vein (Vpv), complication rates and average hospitalization time of 2 groups were compared. Results The rates of PVT in experimental group and control group were 16.1% and 44% in 2 weeks after splenectomy, 12.5% and 40.0% in 4 weeks after splenectomy, 8.9% and 38.0% in 12 weeks after splenectomy, 7.1% and 34.0% in 24 weeks after splenectomy, 7.1% and 32.0% in 48 weeks after splenectomy, respectively. The levels of total bilirubin (TBil), direct bilirubin (DBil), alanine aminotransferase (ALT) and Child-Pugh score of experimental group in week 2, 4, 12, 24 and 48 after splenectomy were significantly lower than those of control group (P<0.05), respectively. The Dpv of experimental group was wider than that of control group, and the Vpv of experimental group was faster than that of control group in week 2, 4, 12, 24 and 48, P<0.05. At week 48, the rates of alimentary tract hemorrhage of experimental group and control group were 3.6% and 10.0% (P>0.05), the rates of hepatic encephalopathy of the 2 groups were1.8% and 8.0% (P>0.05), the rates of intestinal necrosis of the 2 groups were 1.8% and 6.0% (P>0.05), the rates of ascites of the 2 groups were 14.3% and 32.0% (P<0.05). The average hospitalization time of experimental group (10.8 ± 2.9 days) was significantly shorter than that of control group (15.9 ± 4.6 days), P<0.05. No obvious adverse reaction was observed during the period of anticoagulation therapy. Conclusion Anticoagulation therapy can effectively reduce PVT risk after splenectomy in cirrhosis patients, with satisfactory safety.
    The value of left ventricular PSD using ultrasond in cirrhosis with different Child-Pugh grading
    WANG Xue-wei, HUANG Xiao-yun, PANG Chang-xu, QIAO Chao-feng, LI Cai-xia
    2022, 27(2):  174-177. 
    Asbtract ( 274 )   PDF (695KB) ( 198 )  
    References | Related Articles | Metrics
    Objective To investigate the expression level and clinical value of left ventricular peak strain dispersion (PSD) in cirrhosis patients with different Child-Pugh grading. Methods One hundred and sixteen patients with liver cirrhosis admitted to our hospital from October 2018 to October 2020 were enrolled, all of them underwent ultrasound examination. The PSD value and liver function indexes were recorded, and the unconditional logistic analysis was used to analyze the relationship between Child-Pugh grading and PSD. Results Among the 116 patients, 42 cases were Child-Pugh grade A, with PSD as (40.4 ± 8.2) ms and the course of disease as (2.6 ± 0.7) years; 48 cases were grade B, with PSD as (52.8 ± 5.3) ms and the course of disease as (3.7 ± 1.1) years; 26 cases were grade C, with PSD as (58.7 ± 6.6)ms and the course of disease as (4.8 ± 0.9) years. PSD and the course of disease among patients with different Child-Pugh grading were compared with significant differences (P<0.05). The serum CA125 levels of patients with Child-Pugh A, B, C were [(80.8 ± 25.4) U/mL, (193.7 ± 52.0) U/m, (250.6 ± 71.1) U/mL], the serum-ascites albumin gradient (SAAG) levels of patients with Child-Pugh A, B, C were [(14.0 ± 3.8)g/L, (17.9 ± 3.6)g/L, (22.3 ± 4.4)g/L], with significant differences (P<0.05). The unconditional logistic regression analysis showed that the serum CA125 (95%CI=1.071-2.478, OR=1.629, P=0.023), SAAG (95%CI=1.328-3.242, OR=2.075, P=0.001) and PSD (95%CI=1.334-5.665, OR=2.749, P=0.006) were risk factors for decompensated cirrhosis. The PSD (95%CI=1.102-2.399, OR=1.626, P=0.014) was a risk factor for Child-Pugh C in patients with cirrhosis. The receiver operator characteristic (ROC) curve showed that the area under the curve (AUC) of PSD in predicting the Child-Pugh C was 0.752 (SE=0.074, 95%CI=0.608-0.896, P=0.007), the sensitivity was 0.846, and the specificity was 0.550. Conclusion The PSD is closely related to Child-Pugh grading of patients with cirrhosis. PSD is helpful to evaluate the liver function, which might provide guidance for clinical interference.
    Influence of S gene mutation on the expressions of serum AFP, PTX3 and prognosis of patients with hepatitis B virus-related cirrhosis
    QIN Xu, HOU Zhi-yun, ZHANG Song, MA Li, CHAO Hao-peng
    2022, 27(2):  178-181. 
    Asbtract ( 206 )   PDF (669KB) ( 213 )  
    References | Related Articles | Metrics
    Objective To investigate S gene mutation of hepatitis B virus (HBV) and to detect the levels of serum alpha fetoprotein (AFP) and pentraxin 3 (PTX3) in patients with HBV-related cirrhosis. Methods A total of 76 patients with HBV-related cirrhosis admitted to our hospital from July 2017 to June 2019 were selected as the study objects (cirrhosis group). Meanwhile, 87 patients with chronic hepatitis B (CHB) were selected as the control group (hepatitis group). Patients in cirrhosis group were divided into S gene mutation group (22 cases) and S gene nonmutation group (54 cases) according to whether the mutation of S gene occurred. The S gene mutation of HBV was detected by semi-nested polymerase chain reaction (PCR). The levels of AFP and PTX3 were detected by enzyme-linked immunosorbent assay (ELISA). The levels of serum total bilirubin (TBil), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were detected by automatic biochemical analyzer. Pearson method was used to analyze the correlation between liver function indexes and serum levels of AFP, PTX of patients in S gene mutation group. In addition, multivariate logistic regression was used to analyze factors affecting the prognosis of patients with HBV-related cirrhosis. Results The level of TBil [(42.59 ± 6.81) mol/L] and proportion of patients (22/54) with S gene mutation in cirrhosis group were higher than those in hepatitis group [(25.46 ± 7.32), (9/78)], the levels of AST [(156.83 ± 24.57) U/L], ALT [(125.31 ± 30.25) U/L] in cirrhosis group were lower than those in hepatitis group [(238.46 ± 40.22) U/L, (193.74 ± 42.81) U/L] (t=15.395, 9.114, 15.362, 11.626, all P<0.05); The levels of serum AFP (5.98 ± 2.01) ng/mL and PTX3 (5.24 ± 1.43) μg/L in S gene mutation group were higher than those in S gene nonmutation group [(4.86 ± 1.34) ng/mL, (3.84 ± 1.05) μg/L] (t=2.839, 4.729, all P<0.05). The levels of serum AFP and PTX3 were positively correlated with TBil (r=0.502, 0.479, all P<0.05), negatively correlated with AST and ALT (P<0.05) in patients with HBV-related cirrhosis and S gene mutation. S gene mutation was related to the prognosis of patients with HBV-related cirrhosis (r=0.553, P<0.05) and the proportion of poor prognosis was higher than that of good prognosis (86.36% VS 13.64%). S gene mutation and AFP were independent risk factors for the poor prognosis of patients with HBV-related cirrhosis (P<0.05). Conclusion S gene mutation may induce the increased levels of serum AFP and PTX3 in patients with HBV-related cirrhosis, and may be a significant index in predicting the adverse prognosis.
    Liver Cancer
    An analysis of the prognostic influencing factors of intrahepatic cholangiocarcinoma
    MIAO Hui, WAN Xu-ying
    2022, 27(2):  182-184. 
    Asbtract ( 390 )   PDF (658KB) ( 274 )  
    References | Related Articles | Metrics
    Objective To further clarify the prognostic factors of intrahepatic cholangiocarcinoma. Methods The data of 186 patients with intrahepatic cholangiocarcinoma who were admitted from January 2015 to January 2020 were retrospectively collected. The survival status of all patients was followed up by telephone. Multivariate analysis was used to analyze the influencing factors of overall survival. Kaplan-Mier analysis was used to describe the overall survival and disease progression free period. Cox regression model was used to analyze the prognostic factors. Results The 1-, 3-, and 5-year survival rates were 80.6%, 32.2%, and 17.4%, respectively; the 1-, 3-, and 5-year progression free survival rates were 57.6%, 22.9%, and 13.0%, respectively. Multivariate analysis showed that TNM stage IV (HR: 2.77; 95%CI: 1.43-5.36; P=0.002), radical surgery (HR: 0.47; 95%CI: 0.26-0.84; P=0.012), lymph node metastasis (HR: 2.11; 95%CI: 1.33-3.35; P=0.001), vascular invasion (HR: 1.74; 95%CI: 1.04-2.89; P=0.033) were independent factors affecting overall survival. Conclusion TNM stage IV, radical operation, lymph node metastasis and vascular invasion are independent factors affecting the overall survival of patients with intrahepatic cholangiocarcinoma.
    Clinical effect of embolization with polyvinyl alcohol-loaded microspheres for liver metastases from colon cancer
    LIU Li, CHEN Jia-bing, CHEN Cheng
    2022, 27(2):  185-187. 
    Asbtract ( 519 )   PDF (654KB) ( 264 )  
    References | Related Articles | Metrics
    Objective To investigate the clinical effect of embolization with polyvinyl alcohol-loaded microspheres for liver metastases from colon cancer. Methods Eighty-six patients with liver metastases from colon cancer who were admitted from January 2020 to January 2021 were selected as the study subjects. They were divided into a control group and an experimental group by random number method, each with 43 cases. The control group was treated with traditional embolization therapy (lipiodol in combination with epirubicin), and the experimental group was treated with new embolization therapy (polyvinyl alcohol drug-loaded microspheres in combination with epirubicin). Liver function levels, tumor necrosis rate, clinical efficacy, and adverse reactions were compared between these two groups of patients after treatment. Results The disease remission rate and disease control rate of the experimental group were 79.07% (34/43) and 95.35% (41/43), respectively. The disease remission rate and disease control rate of the control group were 51.16% (22/43) and 88.37% (38/43), respectively. The disease remission rate and tumor necrosis rate of the experimental group were significantly higher than those of the control group (P<0.05). The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and albumin (Alb) in the experimental group were (35.39±7.65) U/L, (36.87±7.68) U/L, and (38.21±7.54) g/L, respectively. The levels of ALT, AST and Alb in the control group were (48.14±10.36) U/L, (50.24±11.54) U/L, and (31.24±6.47) g/L, respectively. The levels of ALT and AST in the test group were significantly lower than those in the control group, and the Alb levels in the test group were significantly higher than those in the control group (P<0.05). The incidence of gastrointestinal reactions, abdominal pain, and fever in the test group were significantly lower than those in the control group (P<0.05). Conclusion Interventional embolization with polyvinyl alcohol-loaded microspheres for liver metastases from colon cancer can effectively increase tumor necrosis rate, disease remission rate, protect liver function, and reduce adverse reactions.
    The expression and clinical significance of AURKB and TP53 in hepatocellular carcinoma
    YANG Yi, XI Zi-han, ZHANG Lin-ying
    2022, 27(2):  188-192. 
    Asbtract ( 236 )   PDF (714KB) ( 263 )  
    References | Related Articles | Metrics
    Objective To explore the expression of Aurora kinase B (AURKB) and tumor protein P53 (TP53) in hepatocellular carcinoma (HCC) tissues and their relationship with the clinicopathological characteristics and prognosis of the HCC patients. Methods Ualcan database was used for analyzing the expression of AURKB and TP53 in normal liver tissues and HCC tissues. A total of 95 HCC patients with stage II tumors who were diagnosed and treated from April 2015 to January 2018 were selected as the research objects. Real-time fluorescent quantitative PCR (qRT-PCR) method was used to detect the mRNA expression levels of AURKB and TP53 in HCC and the adjacent normal tissues. Chi-square test was used to analyze the relationship between the mRNA expression levels of AURKB and TP53 in HCC tissues and clinicopathological characteristics; Pearson method was used to analyze the correlation between AURKB and TP53 mRNA expression levels in HCC tissues; Kaplan-Meier survival curve was used to analyze the relationship between the mRNA expression levels of AURKB and TP53 in HCC tissues and the prognosis of HCC patients; COX regression analysis was used to identify the factors affecting the prognosis of HCC patients. Results The mRNA expression levels of AURKB and TP53 in HCC tissues [5.00(2.12, 10.575)、19.91(12.77, 29.72)] in Ualcan database were higher than those in normal liver tissues [0.27(0.19, 0.88)、13.37(11.24, 15.29)](P<0.05). By Quantitative real time polymerase chain reaction(qRT-PCR)method it was found that the mRNA expression levels of AURKB and TP53 in HCC tissues [(1.82±0.61), (1.75±0.59)] were higher than those of the adjacent normal tissues [(1.01±0.34), (1.04±0.35)](P<0.05); the mRNA expression levels of AURKB and TP53 in HCC tissues were positively correlated with tumor metastasis (P<0.05), and negatively correlated with the degree of tumor differentiation (P<0.05); the mRNA expression level of AURKB in HCC tissues was positively correlated with that of TP53 (P<0.05); the 36-month cumulative survival rate of HCC patients in the AURKB and TP53 high expression groups was lower than that in the AURKB and TP53 low expression groups (P<0.05); Lesion metastasis, AURKB and TP53 expression levels were all independent risk factors associated with the poor prognosis of HCC patients (P<0.05). Conclusion The mRNA expression levels of AURKB and TP53 in HCC tissues are relatively higher than those of the adjacent normal tissues, both of which are related to the clinicopathological characteristics and prognosis of HCC patients. AURKB and TP53 are expected to be indicators for evaluating the prognosis of HCC patients.
    Application of T2WI sequence image TA in the differential diagnosis of nodules and small hepatocellular carcinoma under the background of liver cirrhosis
    FENG Quan-ye, GENG Cheng-jun, YIN Hui-kang
    2022, 27(2):  193-195. 
    Asbtract ( 261 )   PDF (694KB) ( 218 )  
    References | Related Articles | Metrics
    Objective To study on the application value of T2 weighted image (T2WI) sequence texture analysis (TA) in the differential diagnosis of proliferative nodules (DNs) and small hepatocellular carcinoma (sHCC) under the background of liver cirrhosis. Methods The clinical data of 76 patients admitted from January 2016 to November 2020 who had single cirrhotic nodule (diameter≤3 cm) confirmed by surgery and pathology were retrospectively analyzed. Within them 48 patients were diagnosed as sHCC (sHCC group) and 28 patients were diagnosed as DNs (DNs group). All patients received operation and obtained pathological diagnosis. Routine magnetic resonance imaging (MRI) examinations were performed in both groups of patients at 1 week before operation. Routine T2WI sequence-TA analysis was performed. The axial T2WI image of the largest section of the nodule was selected, and the region of interest (ROI) was manually outlined by Image J software. The gray level co-occurrence matrix and histogram texture parameters were extracted, including energy, entropy, inverse gap, correlation, contrast, average, kurtosis and skewness. The gray level co-occurrence matrix and histogram texture parameters of the two groups were compared, and the receiver operating characteristic curve (ROC) was used to evaluate the effectiveness of the above texture parameters for the differential diagnosis of DNs and sHCC under the background of liver cirrhosis. Results In SHCC group, the energy and the correlation were (15.50± 7.25)×10-4 and (15.35 ±7.40)×10-4, respectively, which was significantly lower than those of (24. 58± 12.28)×10-4 and (33.72 ± 14.71)×10-4 in DNS group (P<0.05). The Entropy in SHCC group was (7. 00 ± 0.32), which was significantly higher than (6. 62 ± 0.63)in DNS group(P<0.05). The inverse difference, contrast, average, kurtosis and skewness of sHCC group had no significant difference compared with those of DNs group (P>0.05). ROC analysis showed that energy, entropy and correlation had a certain differential diagnosis efficacy on DNs and sHCC on the background of liver cirrhosis, and the area under the curve was 0.693, 0.648 and 0.831, respectively. Conclusion Conventional T2WI sequence TA gray level co-occurrence matrix and histogram texture parameters energy, entropy, correlation have high efficacies in the differential diagnosis of DNs and sHCC under the background of liver cirrhosis, thus are recommended for clinical application.
    Prediction of post-hepatectomy liver failure for hepatocellular carcinoma by model for end-stage liver disease and standardized future liver remnant
    ZHANG Feng-xiao, BAI Xue-song, HU Jinghua
    2022, 27(2):  196-198. 
    Asbtract ( 273 )   PDF (661KB) ( 201 )  
    References | Related Articles | Metrics
    Objective To evaluate the value of standardized future liver remnant (sFLR) and score of model for end-stage liver disease (MELD) in predicting post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC). Methods From October 2015 to February 2021, seventy-four HCC patients including 58 males and 16 females who underwent abdominal three-dimensional CT reconstruction and hepatectomy were enrolled in this study. Univariate and multivariate Logistic regression analysis were used to explore the influencing factors related to PHLF. Receiver operating characteristic curve (ROC) analysis was used to determine the independent influencing factors of PHLF. Results There were 28 PHLF cases (PHLF group) and 46 non-PHLF cases (non-PHLF group) in 74 HCC patients. The PLT, Alb, sFLR and MELD scores of patients in PHLF group and non-PHLF group were 123 (29, 238)×109/L and 168 (38, 538)×109/L, 36.3 (26.0, 41.2) g/L and 42.8 (25.6, 48.8) g/L, 0.50 (0.38, 0.78) and 0.67(0.36, 0.99), 9 (6,12) points and 7 (6,10) points, respectively, with statistically significant differences (P<0.05). There was no significant difference in age, sex, PT, INR, ALT, HBsAg and tumor diameter between these two groups (P>0.05). The scores of PLT, Alb, sFLR and MELD were included in multivariate Logistic regression analysis, and the result showed that PLT, Alb, sFLR and MELD were independent predictors of PHLF in HCC patients (P<0.05). The cutoff value, sensitivity and specificity of sFLR in diagnosing PHLF in HCC patients were 0.54, 76.9% and 73.9%, respectively, while the cutoff value, sensitivity and specificity of MELD score in diagnosing PHLF in HCC patients were 8.5, 53.8% and 82.6%, respectively. The AUC value of sFLR in combination with MELD score in diagnosing PHLF in HCC patients were significantly higher than that of sFLR or MELD score alone (P<0.05). Conclusion sFLR in combination with MELD score is an effective index to predict PHLF in HCC patients. This prediction model can effectively guide the early treatment, improve prognosis and reduce mortality of HCC patients after hepatectomy, and provide a new method for preoperative evaluation.
    The value of US-CT/MRI fusion imaging technology in precision radiofrequency therapy of primary liver cancer
    WANG Bin, QI Xian-wei, ZHANG Xian-liang
    2022, 27(2):  199-202. 
    Asbtract ( 264 )   PDF (754KB) ( 324 )  
    References | Related Articles | Metrics
    Objective To investigate the value of US-CT /MRI fusion imaging in the precision radiofrequency (RF) therapy of primary liver cancer. Methods A total of 50 patients with primary liver cancer admitted from January 2014 to January 2019 were selected as the study subjects. According to whether the lesions were clearly displayed by conventional ultrasound, they were divided into the following two groups: 19 cases in the observation group with difficult ultrasound display, and 31 cases in the control group with clear ultrasound display. The observation group was guided by US-CT/MRI fusion imaging during RF ablation, while the control group was guided by conventional ultrasound during RF ablation. The completion of radiofrequency ablation, intraoperative supplementary ablation, postoperative complete ablation, postoperative complications, and 2-year survival rate were recorded in both groups. Results The completed RF ablation rates of the two groups were 94.74% and 100.00%, the intraoperative supplementary ablation rates of the two groups were 26.32% and 3.23%, and the postoperative complete ablation rates of the two groups were 100.00% and 93.55%, respectively. Compared with the control group, the observation group had a higher intraoperative supplementary ablation rate (P<0.05). There was no significant difference in completed RF ablation and postoperative complete ablation between the two groups (P>0.05). Within 2 years after treatment, 3 cases (15.79%) died in the observation group and 6 cases (19.35%) died in the control group. There was no significant difference in the 2-year survival rate between these two groups (P>0.05). The incidence of postoperative complications in these two groups was 0.00% and 3.23%, respectively. There was no significant difference in the incidence of postoperative complications between these two groups (P> 0.05). Conclusion US-CT/MRI fusion imaging has higher complete ablation rate and better safety in accurate radiofrequency ablation of primary liver cancer. For Lesions that are difficult to be detected by conventional ultrasound, US-CT/MRI fusion imaging can provide clear imaging thus has better clinical application value.
    RNA-binding protein CSTF2 promotes the proliferation and migration of hepatocellular carcinoma cells by regulating MCM6
    HE Xiao-yan, ZHANG Qiang-nu, YANG Liu, WANG Gui-zhi
    2022, 27(2):  203-209. 
    Asbtract ( 277 )   PDF (1378KB) ( 279 )  
    References | Related Articles | Metrics
    Objective To explore the clinical significance of cleavage stimulation factor 2 (CSTF2) expresson in hepatocellular carcinoma (HCC), and its functional and molecular mechanism for the biology of HCC cells. Methods Public HCC-related datasets were collected and analyzed for the difference of CSTF2 expression between HCC and pericarcinoma tissues. Immunohistochemical analysis was used to validate the differential protein expression of CSTF2. The relationship between the expression level of CSTF2 and the clinical characteristics and prognosis of HCC patients was further analyzed. Correlation analysis was performed to identify those genes that are significantly related to CSTF2. In in vitro study, cultured HCC Cells were transfected with CSTF2 expression plasmid or MCM6 siRNA to up-regulate or down-regulate the genes' expression, respectively. CCK-8 test was used to analyze the proliferation. and wound healing assay was used to analyze the migration of HCC cells. The expression levels of CSTF2 and MCM6 in each group of cells were analyzed by qRT-PCR and western blot. Results CSTF2 was significantly up-regulated in cancer tissues in nine HCC microchips and two HCC RNA sequencing public data. High expression of CSTF2 indicated a lower overall survival rate and disease-free survival rate. The expression of CSTF2 was closely related to the tumor size, AFP level, TNM staging and vascular invasion of HCC patients. The expression of MCM6 mRNA in liver cancer tissue was positively correlated with that of CSTF2. Overexpression of CSTF2 promoted the proliferation and migration of HCC cells, and up-regulated the MCM6 level in the cells. Inhibiting the expression of MCM6 partially eliminated the cancer-promoting effect of CSTF2. Conclusion CSTF2 promotes HCC growth and metastasis via up-regulating MCM6. Both CSTF2 and MCM6 may become potential molecular targets for the treatment of HCC.
    The value of PIVKA Ⅱ and serum AFP - L3 levels for evaluating the prognosis of primary liver cancer after TACE Therapy
    JI Qin, SHEN Yu-chneg, SHAO Chun-yan
    2022, 27(2):  210-212. 
    Asbtract ( 215 )   PDF (653KB) ( 459 )  
    References | Related Articles | Metrics
    Objective To investigate the clininal value of joint detection of abnormal serum prothrombin (PIVKA-Ⅱ) and AFP different plastid 3 (AFP-L3) in patients with primary hepatocellular carcinoma (HCC) after conventional transcatheter arterial chemoembolization (TACE) therapy. Methods 63 HCC patients who underwent TACE were divided into >50% and <50% reduction subgroups according to the change of liver lesion size (in diameter), and into complete response (CR), partial response (PR), disease stability (SD) and disease progression (PD) subgroups according to the efficacy. Serum PIVKA - Ⅱ and AFP - L3 levels was detected and analyzed with Pearson analysis. Results Serum PIVKA-Ⅱ and AFP-L3 levels at 4 weeks and 8 weeks after surgery were lower than those before surgery, and showed a decreasing trend (F=12.478, 10.719, both P<0.05). Serum PIVKa-Ⅱ and AFP-L3 levels in >50% reduction subgroup were lower than those in <50% subgroup (t=7.873, 8.264, all P<0.05). Serum PIVKa-Ⅱ and AFP-L3 levels in CR group were lower than those in PR, SD and PD groups, and showed an increasing trend in these groups, respectively (F=15.682, 9.825, all P<0.05). After Pearson correlation analysis, the sensitivity and specificity of combined detection of serum PIVKa-Ⅱ and AFP-L3 levels were higher than those of single index detection (87.61% and 93.26%, both P<0.05). Conclusion A joint detection of PIVKA Ⅱ and serum AFP - L3 levels has high clinical value for evaluating the prognosis of HCC patients post TACE therapy.
    The mechanism of lncRNA TSIX inhibiting proliferation and invasion of hepatocellular carcinoma cell by targeting miR-548-a-3p
    WANG Jia-le, LI Cheng, LI Guang-ming
    2022, 27(2):  213-217. 
    Asbtract ( 145 )   PDF (834KB) ( 353 )  
    References | Related Articles | Metrics
    Objective To investigate the mechanism of lncRNA TSIX inhibiting proliferation and invasion of hepatocellular carcinoma cell by targeting miR-548-a-3p. Methods The liver cancer cell line Huh7 group, lncRNA TSIX mimics group, and lncRNA TSIX inhibitor group were set up. After 48 hours of cell culturing in each group, the cell viability was measured by MTT method, and the number of single clones formed by crystal violet staining was measured, and the apoptosis level was measured by flow cytometry. The cell invasion level was measured by transwell chamber, and the lncRNA TSIX and miR-548-a-3p levels were measured by RT-PCR method. Results The OD value, survival rate, number of colonies formed, and number of membrane penetration in the lncRNA TSIX mimics group were lower than those in the Huh7 group (t=8.725, 5.437, 120.834, 64.321, P<0.05), and the OD value, survival rate, number of colonies formed, number of membrane penetration in the lncRNA TSIX inhibitor group were higher than those in the Huh7 group and lncRNA TSIX inhibitor group (t=4.124, 3.784, 10.462, 7.965, 37.192, 174.632, 30.703, 104.562, P<0.05). The apoptotic rate and lncRNA TSIX in the lncRNA TSIX mimics group was higher than those in the Huh7 group [(18.52±2.45) vs (15.63±2.13), (4.47±0.22) vs (2.89±0.21)] (t=10.531, 12.372, P<0.05), and the apoptotic rate and lncRNA TSIX in the lncRNA TSIX inhibitor group was lower than those in the Huh7 group and the lncRNA TSIX inhibitor group [(8.14±2.45) vs (15.63±2.13), (18.52±2.45); (1.58±0.25) vs (2.89±0.21), (4.47±0.22)] (t=37.385, 48.021, 30.703, 104.562, P<0.05). The miR-548-a-3p in lncRNA TSIX mimics group was lower than that in Huh7 cell group [(2.39±0.19) vs (4.87±0.20)] (t=11.265, P<0.05), and miR-548-a-3p in lncRNA TSIX inhibitor group was higher than that in Huh7 group and lncRNA TSIX inhibitor group [(6.32±0.19) vs (4.87±0.20), (2.39±0.19)] (t=6.612, 10.058, P<0.05). Conclusion LncRNA Tsix significantly inhibited the proliferation and invasion of HCC cells and promoted the apoptosis of HCC cells. The mechanism may be related to the negative regulation of miR-548-a-3p by lncRNA Tsix.
    Viral Hepatitis
    Clinical features and risk factors of acute hepatitis E
    LIU Yu, MEI Xue, ZHANG Yu-yi, ZOU Ying, GUO Hong-ying, YUAN Wei, WANG Jie-fei, QIAN Zhi-ping, ZHANG Zheng-guo
    2022, 27(2):  218-221. 
    Asbtract ( 331 )   PDF (670KB) ( 236 )  
    References | Related Articles | Metrics
    Objective To analyze the clinical characteristics and risk factors of acute hepatitis E. Methods Clinical data of 179 patients diagnosed with acute hepatitis E (AHE) in Shanghai Public Health Clinical Center were collected and their clinical characteristics were summarized. Results 91 of them were over 60 years old, 129 were males, 37 cases were complicated with underlying basic liver diseases, 20 cases were HBV and HEV combined infection and 157 cases with only HEV infection, 158 cases were improved. Compared with patients under 60 years old, those patients over 60 years old showed significantly higher ALT and TBIL levels, lower GGT and Alb levels and longer hospital stay. Compared with females, males showed significantly higher TBil, PT and the liver stiffness value levels, longer hospital stay. Compared with those patients without basic liver diseases, those patients with basic liver diseases showed significantly longer hospital stay. Compared with only HEV infection, those patients with HBV and HEV combined infection showed significantly longer hospital stay. Compared with those improved patients, invalid group had more males, more occurred liver failure, with higher AST, TBil, PT and the liver stiffness value levels, lower GGT and Alb levels. TBil (P=0.001), ALB (P=0.041), PT (P=0.009) were risk factors affecting the prognosis. Conclusion In patients with AHE, there is a higher proportion of males, elderly and males are relatively more serious, elderly, males, combined basic liver disease, HBV and HEV combined infection have relatively longer hospital stay. TBil, Alb, PT are risk factors affecting the prognosis.
    Clinical observation of ETV combined with TDF in the treatment of 28 cases low-level viremia chronic hepatitis B with NAS
    SONG Qing-run, GAO Feng, YANG Xiao-ping, LIU Jun-qing, XIANG Long-chun, HAN Li-ying
    2022, 27(2):  222-224. 
    Asbtract ( 253 )   PDF (655KB) ( 201 )  
    References | Related Articles | Metrics
    Objective To analyze and evaluate the efficacy and feasibility of ETV with TDF in the treatment of low-level viremia (LLV) chronic hepatitis B patients with NAS. Methods The patients with HBV DNA less than 500 IU/ml were treated with nucleoside (acid) analogues (NAs) for at least 48 weeks. The patients with high sensitive detection value between 20 IU/ml and 2000 IU/ml were selected as the research objects. On the basis of necessary conventional treatment, the patients were treated with ETV 0.5 mg, qN, TDF 300 mg, qd for antiviral therapy. Results With the extension of treatment time, the virological response rate of patients in this group was improved. The complete response rate was 64.3% (18/28) at 48W, and the total response rate was 96.4% (27/28). There was no significant difference between the two groups (P>0.05). Conclusion The quantitative detection of high sensitivity HBV DNA can realize the diagnosis of LLV in patients with chronic hepatitis B. The effect of ETV combined with TDF in the treatment of NAs in patients with chronic hepatitis B is good with less adverse reactions, which is worthy of clinical application.
    Observation of inflammation grade and fibrosis stage in chronic hepatitis B patients with low level of HBsAg
    XIAO Shan-shan, YANG Qiao-hong, LI Jian-ting
    2022, 27(2):  225-227. 
    Asbtract ( 299 )   PDF (714KB) ( 212 )  
    References | Related Articles | Metrics
    Objective To observe the characteristics of inflammation grade and fibrosis stage in patients with chronic hepatitis B (CHB) with low level of hepatitis B surface antigen (HBsAg). Methods We selected 157 cases of low level of HBsAg in CHB patients from May 2018 to May 2020, all patients admitted to hospital after receiving liver biopsy before treatment, serum HBsAg and HBV DNA, platelet (PLT), total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST) examination. According to the liver puncture results, the differences of the above serum indexes among patients with different grades of inflammatory activity and fibrosis stages were analyzed. Finally, Spearman rank correlation analysis was used to test the correlation between serum PLT and the fibrotic grading period of CHB patients with low HBsAg levels. Results Among 157 CHB patients, the inflammatory activity grades of 43 cases were G1 grade, 56 cases were G2 grade, 40 cases were G3 grade, and 18 cases were G4 grade. Fibrosis stages of 44 cases were S1 stage, 53 cases with S2 stage, 42 cases with S3 stage, and 18 cases with S4 stage. Comparison of levels of HBsAg, HBV DNA, PLT, TBIL, ALT and AST in patients with different grades of inflammatory activity (P>0.05). The levels of HBsAg, HBV DNA, TBIL, ALT and AST in patients with different fibrosis stages were compared (P>0.05). PLT levels in patients with fibrosis stage S1, 2, 3 and 4 were (214.15 ± 24.16) × 109/L, (174.26 ± 15.06) × 109/L, (144.75 ± 10.46) × 109/L, (130.76 ± 5.56) × 109/L, respectively. PLT levels in patients with different fibrosis stages were S1 > S2 > S3 > S4 (P<0.05). The correlation analysis confirmed that PLT was negatively correlated with fibrosis stage in CHB patients with low level of HBsAg (P<0.05). Correlation analysis confirmed that PLT was negatively correlated with fibrosis stage in CHB patients with low HBsAg level (r=-0.516, P<0.05). Conclusion CHB patients with low HBsAg level still had liver tissue inflammation and fibrosis, and the correlation analysis confirmed that PLT level was closely related to fibrosis stage, clinicians should pay attention to it.
    Other Liver Diseases
    The relationship between ursodeoxycholic acid's short-term response and abundance of intestinal flora and the diversity in patients with primary biliary cholangitis
    DING Qin, WANG Jian-dong, YAO han
    2022, 27(2):  228-232. 
    Asbtract ( 217 )   PDF (801KB) ( 299 )  
    References | Related Articles | Metrics
    Objective To analyze the correlation between the abundance and diversity of intestinal flora in patients with primary biliary cholangitis (PBC) and the short-term response of ursodeoxycholic acid (UDCA). Methods 86 patients with PBC admitted to our hospital from May 2015 to May 2021 were selected as the research object (research group), and 86 patients with physical examination at the same time in our hospital were selected as the control (control group). We compared serum biochemical index levels of PBC patients before and one month after treatment. We also compared the differences in abundance and diversity between the research group before and one month after treatment with the control group. Then we evaluated the short-term response of UDCA in the two groups after one month of treatment and analyzed the correlation between the abundance and diversity of PBC patients and the short-term response of UDCA. The predictive value of the abundance and diversity of PBC patients before treatment on the short-term response of UDCA was assessed. Results The levels of TBA, ALT, AST, TBil, WBC and Scr in PBC patients after 1 month of treatment were (16.71 ± 8.29) μmol/L, (27.49 ± 10.25) U/L, (38.52 ± 19.27) U/L, (18.54 ± 7.31) μmol/L, (7.35 ± 1.42)×109/L, (86.31 ± 12.43) μmol/L, which were all lower than those before treatment [(32.27 ± 11.45) μmol/L, (84.37 ± 21.93) U/L, (88.37 ± 31.62) U/L, (27.38 ± 8.12) μmol/L, (14.52 ± 2.17)×109/L, (148.59 ± 23.16) μmol/L], the differences were statistically significant (P<0.05). Before treatment, the abundance (Chao1 index) and diversity level (Shannon index) of the research group were (441.59 ± 35.49) and (2.54 ± 0.68), respectively, which were lower than those of the control group (706.35 ± 42.17, 3.31 ± 0.46), and the difference was statistically significant (P<0.05). After 1 month of treatment, the Chao1 index and Shannon index of the research group were higher than those before treatment, and the difference was statistically significant (P<0.05). And after 1 month of treatment, the Chao1 index and Shannon index of the research group were (631.27 ± 51.36), (3.01±0.59) respectively, were all lower than those in the control group (703.49 ± 42.76), (3.37 ± 0.53), the difference was statistically significant (P<0.05). Spearman correlation analysis showed that the abundance level (r=0.772, P=0.024), diversity level (r=0.683, P=0.037) were positively correlated with short-term UDCA response. ROC analysis showed that the sensitivity of abundance and diversity to ROC prediction of short-term UDCA response in PBC patients were 74.14%, 72.41%, respectively, the specificity were 60.71%, 64.29%, and the area under the curve (AUC) were 0.764 and 0.737, respectively. Conclusion The abundance and diversity of the intestinal flora of PBC patients are positively correlated with the short-term UDCA response, and the abundance and diversity level have a certain clinical predictive power for the short-term UDCA response of PBC patients.
    Correlation between activated protein C level and coagulation function and prognosis in patients with traumatic liver injury
    ZHANG Bei-ke, FAN Yong-gang, ZHANG Ying-nan, XIE Gang-qiang
    2022, 27(2):  233-237. 
    Asbtract ( 180 )   PDF (682KB) ( 274 )  
    References | Related Articles | Metrics
    Objective To explore the changes of activated protein C (aPC) level in patients with traumatic liver injury and analyze its correlation with early coagulation dysfunction and prognosis. Methods From March 2016 to July 2019, 80 patients with traumatic liver injury in the Department of Gastrointestinal Hepatobiliary Surgery in our hospital were selected. After admission (at the emergency room), blood samples were collected and tested for aPC, protein C (PC), coagulation factors, tissue plasminogen activator (t-PA) and D-dimer. According to injury severity score (ISS) and base deficit (BD) levels, patients were divided into 4 groups, named minor injury without significant tissue hypoperfusion (ISS < 16, BD < 6) group, minor injury with significant tissue hypoperfusion (ISS < 16, BD > 6) group, severe injury without significant tissue hypoperfusion (ISS > 16, BD < 6) group and severe injury with significant tissue hypoperfusion (ISS > 16, BD > 6) group. We compared the differences in coagulation parameters and aPC levels in each group. The aPC level of patients were divided into quartiles, then patients were divided into 4 groups according to the aPC level: Q1 group (aPC < 2.71), Q2 group (2.71 < aPC < 4.06), Q3 group (4.06 < aPC < 6.09) and Q4 Group (6.09 > aPC). The differences of coagulation parameters and coagulation factor levels in each group were compared. Results Compared with other groups, the PT and APTT levels of patients in the severe injury group with significant tissue hypoperfusion when they arrived in the emergency room were (15.72 ± 0.40) s and (32.95 ± 1.12) s, respectively, which were significantly longer than those in the other groups (P<0.05), the level of aPC was increased (11.26 ± 2.33 ng/mL), and the level of AP was decreased (75.22 ± 3.50 ng/mL) (P<0.05). The PT and APTT times of patients in the Q4 group were the longest (P<0.05), which were (16.43 ± 1.02) and (38.27 ± 5.46)s, respectively. The levels of coagulation factors Va and VIIIa in the Q4 group were significantly lower (P<0.05), respectively (43.20 ± 5.11) and (200.17 ± 32.53)%, tPA and D-dimer levels were significantly increased (P<0.05), respectively (34.26 ± 4.02) and (23.45 ± 5.68) ng/Ml. Then, aPC/PC ratio was significantly related to ventilator-associated pneumonia, multiple organ failure, acute lung injury, and death (P<0.05). Conclusion Patients with traumatic liver injury are more prone to early coagulation dysfunction in the case of insufficient tissue perfusion and severe trauma, and are accompanied by a significant increase in aPC levels. This process may be related to the inhibition of coagulation factors by aPC, and a higher aPC level at admission indicates a worse prognosis after severe trauma.
    Relationship between intrahepatic cholestasis of pregnancy and fetal growth restriction and adverse pregnancy outcomes
    FAN Jing-jing, WANG Xiao-hong
    2022, 27(2):  238-241. 
    Asbtract ( 222 )   PDF (665KB) ( 216 )  
    References | Related Articles | Metrics
    Objective To investigate the relationship between intrahepatic cholestasis of pregnancy (ICP) and fetal growth restriction and adverse pregnancy outcomes. Methods The clinical data of 72 ICP puerperants treated in our hospital from May 2018 to May 2021 were analyzed retrospectively. According to the severity of ICP, 72 ICP puerperants were divided into mild group(n=42) and severe group(n=30) In addition, 30 normal puerperants examined in our hospital were selected as control group; Fetal growth restriction and adverse pregnancy outcomes were compared among the three groups,In addition, according to the adverse pregnancy outcomes of ICP puerperants, they were divided into good group (n=41) and bad group (n=31). The difference of clinical characteristics between the two groups was observed, and the risk factors of adverse pregnancy outcome were analyzed by logistic regression analysis model. Results The total incidence of fetal growth restriction and adverse pregnancy outcomes in the three groups were compared[33.33%(14/42) vs 56.67%(17/30) vs 10.00%(3/30)], and the difference was statistically significant (P<0.05).The proportion of pregnant puerperants with age ≥ 35 years old, severe ICP, diabetes mellitus in pregnancy and abnormal placental pathology was significantly higher than that in the good group[70.97%(22/31) vs 41.46% (17/41), 54.84% (17/31) vs 31.71% (13/41), 61.29% (19/31) vs 34.15% (14/41), 70.97% (22/31) vs 36.59 (15/41)] (P<0.05).Logistic regression analysis showed that age ≥ 35 years old(OR:4.267,95%CI:1.114-16.344), severe ICP(OR:3.398,95%CI:1.235-9.349), diabetes mellitus in pregnancy(OR:4.217,95%CI:1.182-15.045) and abnormal placenta pathology(OR:3.954,95%CI:1.156-13.524) were the risk factors for poor prognosis of ICP puerperants. Conclusion Severe ICP can significantly increase the incidence of fetal growth restriction and adverse pregnancy outcomes. In addition, elderly puerperants, gestational diabetes mellitus and abnormal placental pathology are risk factors for adverse pregnancy outcomes.